Build­ing on man­u­fac­tur­ing com­mit­ment, BioN­Tech meets with African lead­ers

On the heels of its an­nounce­ment to amp up mR­NA Covid-19 vac­cine man­u­fac­tur­ing in Africa, BioN­Tech an­nounced it is con­sid­er­ing putting vac­cine man­u­fac­tur­ing sites in Rwan­da and Sene­gal to help beef up the con­ti­nent’s sup­ply.

BioN­Tech CEO Ugur Sahin met with Rwan­dan Pres­i­dent Paul Kagame, Eu­ro­pean Com­mis­sion Pres­i­dent Ur­su­la von der Leyen and Sene­galese Pres­i­dent Macky Sall to talk about sus­tain­able vac­cine man­u­fac­tur­ing for Africa, and dis­cuss its al­ready-an­nounced plans to spin its mR­NA vac­ci­na­tion pro­duc­tion in­to malar­ia and tu­ber­cu­lo­sis vac­cine when the need for Covid-19 vac­cines be­comes less se­vere.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER